Cargando…

Grading diabetic retinopathy (DR) using the Scottish grading protocol

Detalles Bibliográficos
Autores principales:	Zachariah, Sonia, Wykes, William, Yorston, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Centre for Eye Health 2015
Materias:	Grading Dr
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944099/ https://www.ncbi.nlm.nih.gov/pubmed/27418727

Ejemplares similares

Grading diabetic retinopathy: an introduction
por: Bascaran, Covadonga
Publicado: (2023)

Grading images for diabetic retinopathy: tips and guidelines
por: Jamison, Catherine, et al.
Publicado: (2023)

The Scottish Diabetic Retinopathy Screening programme
por: Zachariah, Sonia, et al.
Publicado: (2015)

Understanding and managing sight-threatening diabetic retinopathy
por: Yorston, David
Publicado: (2023)

Appointments and Promotions to Grade 14
Publicado: (1966)

Distribution of CERN Staff by Nationality and Grade, December 1, 1954
por: European Organization for Nuclear Research
Publicado: (1954)

Proposal to Offer an Indefinite Appointment at Grade 14 (with CERN Laboratory I) (Fubini)
Publicado: (1972)

Procedure for Appointments and Promotions to Grade 14
Publicado: (1966)

Procedure for Appointments and Promotions to Grade 14
Publicado: (1966)

Cataract and diabetic retinopathy
por: Rice, James
Publicado: (2011)

Comparing the International Clinical Diabetic Retinopathy (ICDR) severity scale
por: Cleland, Charles
Publicado: (2023)

GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines
por: Cuello-Garcia, Carlos A., et al.
Publicado: (2022)

Proposal to Offer an Indefinite Appointment at Grade 14
Publicado: (1972)

Challenges in applying the GRADE approach in public health guidelines and systematic reviews: a concept article from the GRADE Public Health Group
por: Hilton Boon, Michele, et al.
Publicado: (2021)

HGG-08. Lorlatinib for the treatment of ALK fusion positive infant high grade glioma
por: Greenwell, Alyssa, et al.
Publicado: (2022)

LGG-46. MOLECULAR CHARACTERIZATION OF HEMISPHERIC LOW-GRADE GLIOMAS IN CHILDREN
por: Mišove, Adéla, et al.
Publicado: (2020)

LGG-57. SIGNALLING MECHANISMS IN PAEDIATRIC LOW-GRADE GLIOMA
por: Patel, Ankit, et al.
Publicado: (2020)

LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
por: Misek, Sean, et al.
Publicado: (2022)

Using Explicit Thresholds were valuable for judging Benefits and Harms in partially contextualized GRADE Guidelines
por: Neumann, Ignacio, et al.
Publicado: (2022)

Genetic components in diabetic retinopathy
por: Mishra, Bibhudatta, et al.
Publicado: (2016)

HGG-21. MALIGNANT SYNAPTIC PLASTICITY IN PEDIATRIC HIGH-GRADE GLIOMAS
por: Taylor, Kathryn, et al.
Publicado: (2021)

HGG-41. STRUCTURAL VARIANT DRIVERS IN PEDIATRIC HIGH-GRADE GLIOMA
por: Dubois, Frank, et al.
Publicado: (2020)

HGG-22. Uptake of investigational therapy in children with High Grade Glioma
por: Toledano, Helen, et al.
Publicado: (2022)

HGG-53. PROJECT HOPE: “PEDIATRIC AND AYA HIGH-GRADE GLIOMA OMICS PROJECT”- A LONGITUDINAL MOLECULAR LANDSCAPE OF HIGH-GRADE GLIOMAS RESOLVED AT SINGLE-CELL LEVEL
por: Hack, Olivia A, et al.
Publicado: (2020)

LGG-14. LOGGIC (Low Grade Glioma in Children) Core BioClinical Data Bank: Establishment and added clinical value of an international molecular diagnostic registry for pediatric low-grade glioma patients
por: Hardin, Emily C, et al.
Publicado: (2022)

LGG-08. TREATMENT OUTCOMES AND TOLERABILITY OF TRAMETINIB IN PROGRESSIVE CIRCUMSCRIBED LOW-GRADE GLIOMAS
por: Hanzlik, Emily, et al.
Publicado: (2021)

LGG-15. PEDIATRIC LOW-GRADE GLIOMAS IN SAUDI ARABIA: RETROSPECTIVE ANALYSIS OF CHILDREN WITH LOW-GRADE GLIOMAS TREATED IN KING FAHAD MEDICAL CITY KFMC- SINGLE INSTITUTIONAL EXPERIENCE
por: Alammar, Fahad, et al.
Publicado: (2020)

LGG-44. PROGNOSTIC SIGNIFICANCE OF IMAGING CHARACTERISTICS IN PEDIATRIC LOW GRADE GLIOMAS
por: Baig, Muhammad, et al.
Publicado: (2020)

LGG-06. LONG-TERM OUTCOME OF NEWLY DIAGNOSED LOW GRADE GLIOMA
por: Sirachainan, Nongnuch, et al.
Publicado: (2020)

LGG-02. PEDIATRIC LOW-GRADE GLIOMA RISK STRATIFICATION IN THE MOLECULAR ERA
por: Hata, Jessica, et al.
Publicado: (2021)

HGG-44. DEFECTS OF MISMATCH REPAIR PROTEINS IN PEDIATRIC HIGH GRADE GLIOMAS
por: Haberler, Christine, et al.
Publicado: (2020)

LGG-04. Clinical and molecular characterization of metastatic pediatric low grade gliomas
por: Lindsay, Holly, et al.
Publicado: (2022)

HGG-17. Novel Fusion in Congenital Brainstem Diffuse High-Grade Glioma
por: Norris, Gregory, et al.
Publicado: (2022)

LGG-20. Defining subgroups in low grade gliomas by their immune and stromal microenvironment
por: Körner, Meik, et al.
Publicado: (2022)

LGG-36. Analysis of BRAF-related mutations in pediatric low-grade glioma
por: Li, Shaoqun, et al.
Publicado: (2022)

LGG-29. Use of Bevacizumab in Pediatric Low-grade Glioma: Ten-year experience in a single center
por: Rafael, Margarida Simão, et al.
Publicado: (2022)

HGG-27. ANTI-CANCER POTENTIAL OF ARGINASE FOR HIGH-GRADE GLIOMA IN VITRO & IN-VIVO
por: Fung, M K L, et al.
Publicado: (2020)

HGG-24. HIGH-GRADE GLIOMA WITH A NOVEL FUSION GENE OF VCL-ALK
por: Yamamoto, Shunsuke, et al.
Publicado: (2020)

LGG-12. TRAMETINIB FOR PEDIATRIC LOW GRADE GLIOMAS: A SINGLE INSTITUTION EXPERIENCE
por: Barbour, Mustafa, et al.
Publicado: (2020)

LGG-27. TARGETED THERAPY FOR PEDIATRIC LOW-GRADE GLIOMAS AND PLEXIFORM NEUROFIBROMAS WITH TRAMETINIB
por: Nguyen, Tiffany, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m934mtmjk66odcilo30b92lkea